Drugs / TIV 2010/2011 influenza vaccine
TIV 2010/2011 influenza vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01304563 Comparator | Nov 2010 → Feb 2011 | influenza | The University of Hong Kong | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIV 2010/2011 influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01304563 ↗ |
| Known as | Fluzone | “The 2010/2011 TIV used will be Fluzone®, Sanofi-Pasteur for group 3 and Intanza®, Sanofi-Pasteur for group 1,2 and 4.” NCT01304563 ↗ |
| Known as | Intanza | “The 2010/2011 TIV used will be Fluzone®, Sanofi-Pasteur for group 3 and Intanza®, Sanofi-Pasteur for group 1,2 and 4.” NCT01304563 ↗ |
| Modality | Vaccine | “2010/2011 influenza vaccine” NCT01304563 ↗ |
| Route | Intramuscular | “delivered via intramuscular injection” NCT01304563 ↗ |